Changes in Antihypertensive Medication Following Bariatric Surgery.
Gabriel S TajeuEmily JohnsonMason BuccillaCrystal A GadegbekuShane JanickDaniel RubinRohit SoansVikram J EddyDavid B SarwerPublished in: Obesity surgery (2022)
Obesity is a leading cause of hypertension (i.e., high blood pressure [BP]). While hypertension can be managed with antihypertensive medication, substantial weight loss can also lower BP, reducing the need for antihypertensive medication. Articles in this review (n = 60) presented data on antihypertensive medication use among adults pre- and postoperatively. Roux-en-Y gastric bypass was the most studied surgical approach followed by Laparoscopic Sleeve Gastrectomy. Antihypertensive medication was discontinued in a large proportion of patients after surgery, and the mean number of antihypertensive medications decreased by approximately one. In almost a third of the studies, over 75% of participants experienced hypertension remission. All articles aside from two reported a decrease in systolic BP, with about 40% reporting a decrease of ≥ 10 mm Hg.
Keyphrases
- blood pressure
- weight loss
- roux en y gastric bypass
- bariatric surgery
- hypertensive patients
- adverse drug
- heart rate
- gastric bypass
- obese patients
- healthcare
- end stage renal disease
- ejection fraction
- newly diagnosed
- insulin resistance
- chronic kidney disease
- type diabetes
- metabolic syndrome
- prognostic factors
- rheumatoid arthritis
- heart failure
- physical activity
- peritoneal dialysis
- body mass index
- emergency department
- electronic health record
- glycemic control
- adipose tissue
- living cells
- artificial intelligence
- fluorescent probe
- big data
- deep learning